Cilostazol Catalog No.:M9487-2 Smiles: COC1=CC2=C(N)N=C(N=C2C=C1OC)N(C)CCCNC(=O)C1CCCO1

Smiles: COC1=CC2=C(N)N=C(N=C2C=C1OC)N(C)CCCNC(=O)C1CCCO1

Smiles: CN1CCN(CC1)C1=CC2=C(C=C1F)C(=O)C(=CN2CC)C(O)=O

PubMed PMID: 25649658

H2O/c1-15-27-38(10

K562 cells) treatment inhibits MAPK/ERK/JNK downstream signaling and diminishes Jak2/Stat3/Akt expression

Cilostazol Catalog No.:M9487-2 Smiles: COC1=CC2=C(N)N=C(N=C2C=C1OC)N(C)CCCNC(=O)C1CCCO1Cilostazol is a quinolinone derivative medication used in the alleviation of the symptom of claudication in individuals with peripheral vascular disease. Cilostazol is a phosphodiesterase inhibitor with therapeutic focus on cyclic adenosine monophosphate (cAMP). It inhibits platelet aggregation and is a direct arterial vasodilator. Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation. It is